K. Manabe et al. / Bioorg. Med. Chem. 13 (2005) 5154–5158
5157
4.3. A typical experimental procedure for the synthesis of
1-phenyl-1,2,3,4-tetrahydroisoquinoline derivatives12
155.47, 144.48, 137.49, 129.57, 128.99, 128.64, 127.98,
124.11, 120.96, 113.27, 56.03, 38.23, 29.21; IR (KBr,
cmꢀ1) 3417, 3287, 3032, 2925, 2856, 2635, 2379, 2328,
1729. HRMS calcd for C19H15NOÅH+ (M+H+)
226.1232. Found 226.1221.
To a one-necked 10-mL flask equipped with a reflux
condenser, m-tyramine (52.3 mg, 0.38 mmol), benzalde-
hyde (53.8 mg, 0.51 mmol), and pyridine (1.0 mL) were
added successively. The reaction mixture was stirred and
refluxed for 2 h. After cooling the flask at room temper-
ature, a 10% aqueous sodium hydroxide solution was
added to basify the media, and the aqueous layer was
washed with Et2O. To the aqueous layer, 10% aqueous
HCl was added to acidify the media and then, a 28%
aqueous ammonia solution was added to basify the
media again. The organic compounds were extracted
with dichloromethane. The organic layer was dried over
anhydrous sodium sulfate, and evaporated. Pyridine (1.0
mL) was added to the crude reaction mixture, and the
solution was stirred at room temperature. Then, trifluo-
roacetic anhydride (0.5 mL, 9.0 equiv.) was added
slowly, and the reaction mixture was stirred overnight.
The reaction was stopped with 1 N aqueous HCl,
and the organic compounds were extracted with ethyl
acetate. The organic layer was washed with 1 N aqueous
HCl, saturated aqueous sodium bicarbonate, and brine
successively, dried over anhydrous sodium sulfate, and
evaporated. Purification by silica gel chromatography
gave the desired N-protected cyclized products (6-OH
adduct: 45.7 mg, 37%, 8-OH adduct: 11.8 mg, 10%).
To each protected isomer in methanol, an aqueous
sodium hydroxide solution (10 equiv.) was added, and
the reaction mixture was stirred overnight. The depro-
tection reactions proceeded quantitatively, and were
stropped with 1 N aqueous HCl. A saturated aqueous
sodium bicarbonate solution was then added to basify
the media again. After extraction with ethyl acetate, fol-
lowed by drying and concentration, the desired 1,2,3,4-
tetrahydroisoquinoline derivatives were obtained in
pure forms.
4.6. l-(4-tert-Butyl-phenyl)-6-hydroxy-l,2,3,4-
tetrahydroisoquinoline
1H NMR (DMSO-d6) d: 9.09 (br s, 1H), 7.29 (d, 2H,
J = 8.2Hz), 7.13 (d, 2H, J = 8.2Hz), 6.48 (s, 1H), 6.43–
6.36 (m, 2H), 4.82 (s, 1H), 3.04–2.97 (m, 1H), 2.88–
2.74 (m, 2H), 2.65–2.55 (m, 1H), 1.25 (s, 9H); 13C
NMR (DMSO-d6) d: 155.13, 148.95, 142.72, 136.36,
129.36, 128.56, 128.42, 124.64, 114.71, 112.88, 60.32,
41.55, 34.14, 31.21, 29.47; IR (KBr, cmꢀ1) 3429, 3276,
2964, 2875, 2801, 2667, 2600. HRMS calcd for
C19H23NOÅH+ (M+H+) 282.1858. Found 282.1849.
4.7. l-(4-tert-Butyl-phenyl)-8-hydroxy-l,2,3,4-
tetrahydroisoquinoline
1H NMR (DMSO-d6) d: 9.04 (br s, 1H), 7.27–7.17 (m,
2H), 7.01–6.89 (m, 3H,), 6.59 (d, 1H, J = 7.4 Hz), 6.53
(d, 1H, J = 7.4 Hz), 5.04 (s, 1H), 2.82–2.52 (m, 4H),
1.24 (s, 9H); 13C NMR(DMSO-d6) d: 153.81, 148.13,
141.84, 136.91, 127.81, 126.68, 124.58, 124.20, 119.50,
111.81, 53.70, 38.67, 37.21, 34.06, 31.23, 28.66; IR
(KBr, cmꢀ1) 3395, 3284, 3028, 2957, 2873, 2719, 2622.
HRMS calcd for C19H23NOÅH+ (M+H+) 282.1858.
Found 282.1854.
4.8. l-iso-Butyl-6-hydroxy-l,2,3,4-tetrahydroisoquinoline
1H NMR (CD3OD) d: 6.92 (d, 1H, J = 8.4 Hz), 6.58 (dd,
1H, J = 8.4, 2.3 Hz), 6.49 (d, 1H, J = 2.3 Hz), 3.97–3.83
(m, 1H), 3.21–3.08 (m, 1H), 2.93–2.63 (m, 3H), 1.92–
1.77 (m, 1H), 1.67–1.55 (m, 2H), 1.00 (d, 3H, J = 6.4
Hz), 0.97 (d, 3H, J = 6.9 Hz); 13C NMR (CD3OD) d:
184.52, 164.82, 159.27, 156.25, 144.03, 142.48, 82.09,
75.05, 69.39, 58.10, 53.63, 52.34, 49.76; IR (KBr,
cmꢀ1) 3379, 3308, 2958, 2679, 2603, 2377. HRMS calcd
for C13H19NOÅH+ (M+H+) 206.1545. Found 206.1543.
4.4. l-Phenyl-6-hydroxy-l,2,3,4-tetrahydroisoquinoline
1H NMR (DMSO-d6) d: 9.14 (br s, 1H), 7.31–7.16 (m,
5H), 6.52–6.46 (m, 1H), 6.45–6.36 (m, 2H), 4.86 (s,
1H), 3.08–2.96 (m, 1H), 2.90–2.72 (m, 2H), 2.67–2.53
(m, 1H); 1H NMR (CD3OD): d: 7.35–7.16 (m, 5H),
6.56 (d, 1H, J = 2.1 Hz), 6.48 (d, 1H, J = 8.6 Hz), 6.46
(dd, 1H, J = 2.1, 8.6 Hz), 4.98 (s, 1H), 3.21–3.11 (m,
1H), 3.02–2.89 (m, 2H), 2.83–2.69 (m, 1H); 13C NMR
(CD3OD) d: 156.94, 145.51, 137.47, 130.21, 130.21,
129.74, 129.45, 128.52, 115.80, 114.42, 62.42, 29.98; IR
(KBr, cmꢀ1) 3438, 3281, 3034, 2955, 2932, 2790, 2656,
2551. HRMS calcd for C15H15NOÅH+ (M+H+)
226.1232. Found 226.1239.
4.9. 1-iso-Butyl-8-hydroxy-1,2,3,4-tetrahydroisoquinoline
1H NMR (CD3OD) d: 6.93 (dd, 1H, J = 7.7, 8.0 Hz),
6.57 (d, 1H, J = 7.7 Hz), 6.56 (d, 1H, J = 8.0 Hz),
4.30–4.22 (m, 1H), 3.23–3.12 (m, 1H), 3.00–2.80 (m,
2H), 2.76–2.64 (m, 1H), 1.91–1.80 (m, 1H), 1.69–1.58
(m, 2H), 1.04 (d, 3H, J = 6.9 Hz), 0.96 (d, 3H, J = 6.9
Hz); 13C NMR (CD3OD) d: 150.00, 136.25, 127.78,
127.13, 1201.04, 113.30, 49.91, 42.73, 38.33, 29.26,
25.93, 24.56, 21.40; IR (KBr, cmꢀ1) 3410, 3041, 2959,
2864, 2722, 2378, 2338, 1729, 1681. HRMS calcd for
C13H19NOÅH+ (M+H+) 206.1545. Found 206.1543.
4.5. l-Phenyl-8-hydroxy-l,2,3,4-tetrahydroisoquinoline
1H NMR (DMSO-d6) d: 9.06 (br s, 1H), 7.34–7.02 (m,
5H), 6.99 (dd, 1H, J = 7.8 Hz), 6.61 (d, 1H, J = 7.8
Hz), 6.55 (d, 1H, J = 7.8 Hz), 5.10 (s, 1H), 2.87–2.52
(m, 4H); 1H NMR (CD3OD) d: 7.32–7.15 (m, 3H),
7.10 (d, 2H, J = 7.8 Hz), 7.04 (dd, 1H, J = 7.8 Hz),
6.70 (d, 1H, J = 7.8 Hz), 6.55 (d, 1H, J = 7.8 Hz), 5.31
(s, 1H), 3.01–2.71 (m, 4H); 13C NMR (CD3OD) d:
4.10. 1-(2-Pyridyl)-6-hydroxy-1,2,3,4-
tetrahydroisoquinoline
1H NMR (CD3OD) d: 8.56–8.44 (m, 1H), 7.82–7.68 (m,
1H), 7.37–7.27 (m, 1H), 7.26–7.19 (m, 1H), 6.60 (d, 1H,
J = 2.4 Hz), 6.55 (d, 1H, J = 8.6 Hz), 6.50 (d, 1H,